Podchaser Logo
Home
Comparing Anti-EGFR in Left vs. Right-Sided Colorectal Cancer Tumors: Survival Trends from the Latest Clinical Trials

Comparing Anti-EGFR in Left vs. Right-Sided Colorectal Cancer Tumors: Survival Trends from the Latest Clinical Trials

Released Friday, 31st January 2020
Good episode? Give it some love!
Comparing Anti-EGFR in Left vs. Right-Sided Colorectal Cancer Tumors: Survival Trends from the Latest Clinical Trials

Comparing Anti-EGFR in Left vs. Right-Sided Colorectal Cancer Tumors: Survival Trends from the Latest Clinical Trials

Comparing Anti-EGFR in Left vs. Right-Sided Colorectal Cancer Tumors: Survival Trends from the Latest Clinical Trials

Comparing Anti-EGFR in Left vs. Right-Sided Colorectal Cancer Tumors: Survival Trends from the Latest Clinical Trials

Friday, 31st January 2020
Good episode? Give it some love!
Rate Episode

Guest: Putao Cen, MD

Here to give us a breakdown of what the latest clinical trials are saying about anti-EGFR therapies in left versus right-sided colorectal cancer tumors is Dr. Putao Cen, Associate Professor of Medical Oncology at the University of Texas Health Science Center McGovern Medical School.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features